Byatt, Nancy
Cox, Lucille
Moore Simas, Tiffany A.
Kini, Nisha
Biebel, Kathleen
Sankaran, Padma
Swartz, Holly A.
Weinreb, Linda
Funding for this research was provided by:
National Institutes of Health (KL2TR000160, UL1TR000161)
Article History
Received: 20 September 2017
Accepted: 28 February 2018
First Online: 13 March 2018
Compliance with ethical standard
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of The University of Massachusetts Institutional Review Board (who approved the study) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all study participants before they participated in the study.
: The first, third, fourth, and eighth authors have received salary and/or funding support from the Massachusetts Department of Mental Health via the Massachusetts Child Psychiatry Access Program for Moms (MCPAP for Moms). The first author is also the statewide Medical Director of MCPAP for Moms. The first author has served on the Perinatal Depression Advisory Board for the Janssen Disease Interception Accelerator Program and Advisory Boards for Sage Therapeutics. She has also received speaking honoria from Sage Therapeutics and in a council member of the Gerson Lerhman Group. The third author is the Lead Obstetric Liaison for MCPAP for Moms and has served on a Physician Advisory Board for Sage Therapeutics and is a consultant for two research projects. The fifth author has been the Program Director of MCPAP for Moms, and the eight author has served as a Consultant for MCPAP for Moms. The seventh author serves as a consultant for Myriad Genetic, Inc. The second, fourth, and sixth authors declare that they do not have conflicts of interest.